Sulin Zhang

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 28

Top Venues

Journal of medicinal chemistry

Nature immunology

ACS medicinal chemistry letters

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Xuehui Long, Sulin Zhang, Yuliang Wang, Jingjing Chen, Yanlai Lu, Hui Hou, Bichun Lin, Xutong Li, Chang Shen, Ruirui Yang, Huamin Zhu, Rongrong Cui, Duanhua Cao, Geng Chen, Dan Wang, Yun Chen, Sulan Zhai, Zhiqin Zeng, Shusheng Wu, Mengting Lou, Junhong Chen, Jian Zou, Mingyue Zheng, Jun Qin, Xiaoming Wang
Targeting JMJD1C to selectively disrupt tumor T reg cell fitness enhances antitumor immunity. Nature immunology (2024)
Xiaochu Tong, Ning Qu, Xiangtai Kong, Shengkun Ni, Jingyi Zhou, Kun Wang, Lehan Zhang, Yiming Wen, Jiangshan Shi, Sulin Zhang, Xutong Li, Mingyue Zheng
Deep representation learning of chemical-induced transcriptional profile for phenotype-based drug discovery. Nature communications 15 (1) (2024)
Xiaochu Tong, Ning Qu, Xiangtai Kong, Shengkun Ni, Jingyi Zhou, Kun Wang, Lehan Zhang, Yiming Wen, Jiangshan Shi, Sulin Zhang, Xutong Li, Mingyue Zheng
Deep representation learning of chemical-induced transcriptional profile for phenotype-based drug discovery. Nature communications 15 (1) (2024)
Xiong Xie, Qiaoshuai Lan, Jinyi Zhao, Sulin Zhang, Lu Liu, Yumin Zhang, Wei Xu, Maolin Shao, Jingjing Peng, Shuai Xia, Yan Zhu, Keke Zhang, Xianglei Zhang, Ruxue Zhang, Jian Li, Wenhao Dai, Zhen Ge, Shulei Hu, Changyue Yu, Jiang Wang, Dakota Ma, Mingyue Zheng, Haitao Yang, Geng-Fu Xiao, Zihe Rao, Lu Lu, Lei-Ke Zhang, Fang Bai, Yao Zhao, Shibo Jiang, Hong Liu
Structure-based design of pan-coronavirus inhibitors targeting host cathepsin L and calpain-1. Signal transduction and targeted therapy 9 (1) (2024)
Chuan Zhou, Zisheng Fan, Yuejiao Gu, Zhiming Ge, Zhaofan Tao, Rongrong Cui, Yupeng Li, Guizhen Zhou, Ruifeng Huo, Mingshan Gao, Dan Wang, Wei He, Mingyue Zheng, Sulin Zhang, Tianfeng Xu
Design, Synthesis, and Biological Evaluation of Potent and Selective PROTAC Degraders of Oncogenic KRAS G12D . Journal of medicinal chemistry 67 (2) (2024)
Chuan Zhou, Zisheng Fan, Yuejiao Gu, Zhiming Ge, Zhaofan Tao, Rongrong Cui, Yupeng Li, Guizhen Zhou, Ruifeng Huo, Mingshan Gao, Dan Wang, Wei He, Mingyue Zheng, Sulin Zhang, Tianfeng Xu
Design, Synthesis, and Biological Evaluation of Potent and Selective PROTAC Degraders of Oncogenic KRAS G12D . Journal of medicinal chemistry (2024)
Xiaochu Tong, Ning Qu, Xiangtai Kong, Shengkun Ni, Jingyi Zhou, Kun Wang, Lehan Zhang, Yiming Wen, Jiangshan Shi, Sulin Zhang, Xutong Li, Mingyue Zheng
Deep representation learning of chemical-induced transcriptional profile for phenotype-based drug discovery. Nature communications 15 (1) (2024)
Huajie Li, Zhiming Ge, Kexin Lin, Wei He, Qinyu Chu, Mingyue Zheng, Sulin Zhang, Tianfeng Xu
Design, Synthesis, and Bioevaluation of Transcriptional Enhanced Assocciated Domain (TEAD) PROTAC Degraders. ACS medicinal chemistry letters 15 (5) (2024)
Xiong Xie, Qiaoshuai Lan, Jinyi Zhao, Sulin Zhang, Lu Liu, Yumin Zhang, Wei Xu, Maolin Shao, Jingjing Peng, Shuai Xia, Yan Zhu, Keke Zhang, Xianglei Zhang, Ruxue Zhang, Jian Li, Wenhao Dai, Zhen Ge, Shulei Hu, Changyue Yu, Jiang Wang, Dakota Ma, Mingyue Zheng, Haitao Yang, Geng-Fu Xiao, Zihe Rao, Lu Lu, Lei-Ke Zhang, Fang Bai, Yao Zhao, Shibo Jiang, Hong Liu
Structure-based design of pan-coronavirus inhibitors targeting host cathepsin L and calpain-1. Signal transduction and targeted therapy 9 (1) (2024)
Xuehui Long, Sulin Zhang, Yuliang Wang, Jingjing Chen, Yanlai Lu, Hui Hou, Bichun Lin, Xutong Li, Chang Shen, Ruirui Yang, Huamin Zhu, Rongrong Cui, Duanhua Cao, Geng Chen, Dan Wang, Yun Chen, Sulan Zhai, Zhiqin Zeng, Shusheng Wu, Mengting Lou, Junhong Chen, Jian Zou, Mingyue Zheng, Jun Qin, Xiaoming Wang
Targeting JMJD1C to selectively disrupt tumor T reg cell fitness enhances antitumor immunity. Nature immunology 25 (3) (2024)
Xuehui Long, Sulin Zhang, Yuliang Wang, Jingjing Chen, Yanlai Lu, Hui Hou, Bichun Lin, Xutong Li, Chang Shen, Ruirui Yang, Huamin Zhu, Rongrong Cui, Duanhua Cao, Geng Chen, Dan Wang, Yun Chen, Sulan Zhai, Zhiqin Zeng, Shusheng Wu, Mengting Lou, Junhong Chen, Jian Zou, Mingyue Zheng, Jun Qin, Xiaoming Wang
Targeting JMJD1C to selectively disrupt tumor T reg cell fitness enhances antitumor immunity. Nature immunology 25 (3) (2024)
Huajie Li, Zhiming Ge, Kexin Lin, Wei He, Qinyu Chu, Mingyue Zheng, Sulin Zhang, Tianfeng Xu
Design, Synthesis, and Bioevaluation of Transcriptional Enhanced Assocciated Domain (TEAD) PROTAC Degraders. ACS medicinal chemistry letters 15 (5) (2024)
Chuan Zhou, Zisheng Fan, Yuejiao Gu, Zhiming Ge, Zhaofan Tao, Rongrong Cui, Yupeng Li, Guizhen Zhou, Ruifeng Huo, Mingshan Gao, Dan Wang, Wei He, Mingyue Zheng, Sulin Zhang, Tianfeng Xu
Design, Synthesis, and Biological Evaluation of Potent and Selective PROTAC Degraders of Oncogenic KRAS G12D . Journal of medicinal chemistry 67 (2) (2024)
Xiong Xie, Qiaoshuai Lan, Jinyi Zhao, Sulin Zhang, Lu Liu, Yumin Zhang, Wei Xu, Maolin Shao, Jingjing Peng, Shuai Xia, Yan Zhu, Keke Zhang, Xianglei Zhang, Ruxue Zhang, Jian Li, Wenhao Dai, Zhen Ge, Shulei Hu, Changyue Yu, Jiang Wang, Dakota Ma, Mingyue Zheng, Haitao Yang, Geng-Fu Xiao, Zihe Rao, Lu Lu, Lei-Ke Zhang, Fang Bai, Yao Zhao, Shibo Jiang, Hong Liu
Structure-based design of pan-coronavirus inhibitors targeting host cathepsin L and calpain-1. Signal transduction and targeted therapy 9 (1) (2024)
Xuehui Long, Sulin Zhang, Yuliang Wang, Jingjing Chen, Yanlai Lu, Hui Hou, Bichun Lin, Xutong Li, Chang Shen, Ruirui Yang, Huamin Zhu, Rongrong Cui, Duanhua Cao, Geng Chen, Dan Wang, Yun Chen, Sulan Zhai, Zhiqin Zeng, Shusheng Wu, Mengting Lou, Junhong Chen, Jian Zou, Mingyue Zheng, Jun Qin, Xiaoming Wang
Targeting JMJD1C to selectively disrupt tumor T reg cell fitness enhances antitumor immunity. Nature immunology 25 (3) (2024)
Xuehui Long, Sulin Zhang, Yuliang Wang, Jingjing Chen, Yanlai Lu, Hui Hou, Bichun Lin, Xutong Li, Chang Shen, Ruirui Yang, Huamin Zhu, Rongrong Cui, Duanhua Cao, Geng Chen, Dan Wang, Yun Chen, Sulan Zhai, Zhiqin Zeng, Shusheng Wu, Mengting Lou, Junhong Chen, Jian Zou, Mingyue Zheng, Jun Qin, Xiaoming Wang
Targeting JMJD1C to selectively disrupt tumor T reg cell fitness enhances antitumor immunity. Nature immunology 25 (3) (2024)
Chuan Zhou, Zisheng Fan, Yuejiao Gu, Zhiming Ge, Zhaofan Tao, Rongrong Cui, Yupeng Li, Guizhen Zhou, Ruifeng Huo, Mingshan Gao, Dan Wang, Wei He, Mingyue Zheng, Sulin Zhang, Tianfeng Xu
Design, Synthesis, and Biological Evaluation of Potent and Selective PROTAC Degraders of Oncogenic KRAS G12D . Journal of medicinal chemistry 67 (2) (2024)
Chenmao Zhou, Xinyue Hao, Zhengyang Chen, Runze Zhang, Qian Zhou, Zisheng Fan, Mingyue Zheng, Hui Hou, Sulin Zhang, Hao Guo
Synthesis and Biological Evaluation of β-Lactam Derivatives Targeting Speckle-Type POZ Protein (SPOP). ACS medicinal chemistry letters 15 (2) (2024)
Chenmao Zhou, Xinyue Hao, Zhengyang Chen, Runze Zhang, Qian Zhou, Zisheng Fan, Mingyue Zheng, Hui Hou, Sulin Zhang, Hao Guo
Synthesis and Biological Evaluation of β-Lactam Derivatives Targeting Speckle-Type POZ Protein (SPOP). ACS medicinal chemistry letters 15 (2) (2024)
Xuehui Long, Sulin Zhang, Yuliang Wang, Jingjing Chen, Yanlai Lu, Hui Hou, Bichun Lin, Xutong Li, Chang Shen, Ruirui Yang, Huamin Zhu, Rongrong Cui, Duanhua Cao, Geng Chen, Dan Wang, Yun Chen, Sulan Zhai, Zhiqin Zeng, Shusheng Wu, Mengting Lou, Junhong Chen, Jian Zou, Mingyue Zheng, Jun Qin, Xiaoming Wang
Targeting JMJD1C to selectively disrupt tumor T reg cell fitness enhances antitumor immunity. Nature immunology 25 (3) (2024)
Xiong Xie, Qiaoshuai Lan, Jinyi Zhao, Sulin Zhang, Lu Liu, Yumin Zhang, Wei Xu, Maolin Shao, Jingjing Peng, Shuai Xia, Yan Zhu, Keke Zhang, Xianglei Zhang, Ruxue Zhang, Jian Li, Wenhao Dai, Zhen Ge, Shulei Hu, Changyue Yu, Jiang Wang, Dakota Ma, Mingyue Zheng, Haitao Yang, Geng-Fu Xiao, Zihe Rao, Lu Lu, Lei-Ke Zhang, Fang Bai, Yao Zhao, Shibo Jiang, Hong Liu
Structure-based design of pan-coronavirus inhibitors targeting host cathepsin L and calpain-1. Signal transduction and targeted therapy 9 (1) (2024)
Chang Shen, Peijia Xu, Changfa Zhang, Zhaoming Su, Bin Shan, Rui Li, Qibang Sui, Keke Zhang, Zhengyang Chen, Jingyi Zhou, Xiaojie Lu, Kaixian Chen, Mingyue Zheng, Sulin Zhang, Hui Hou
Structure-Activity Relationship Study of 1 H -Pyrrole-3-carbonitrile Derivatives as STING Receptor Agonists. ACS medicinal chemistry letters 14 (8) (2023)
Zehui Zhou, Guizhen Zhou, Chuan Zhou, Zisheng Fan, Rongrong Cui, Yupeng Li, Rui Li, Yuejiao Gu, Huajie Li, Zhiming Ge, Xiaojia Cai, Bing Jiang, Dan Wang, Mingyue Zheng, Tianfeng Xu, Sulin Zhang
Discovery of a Potent, Cooperative, and Selective SOS1 PROTAC ZZ151 with In Vivo Antitumor Efficacy in KRAS-Mutant Cancers. Journal of medicinal chemistry (2023)
Lifan Chen, Zisheng Fan, Jie Chang, Ruirui Yang, Hui Hou, Hao Guo, Yinghui Zhang, Tianbiao Yang, Chenmao Zhou, Qibang Sui, Zhengyang Chen, Chen Zheng, Xinyue Hao, Keke Zhang, Rongrong Cui, Zehong Zhang, Hudson Ma, Yiluan Ding, Naixia Zhang, Xiaojie Lu, Xiaomin Luo, Hualiang Jiang, Sulin Zhang, Mingyue Zheng
Sequence-based drug design as a concept in computational drug design. Nature communications 14 (1) (2023)
Zehui Zhou, Guizhen Zhou, Chuan Zhou, Zisheng Fan, Rongrong Cui, Yupeng Li, Rui Li, Yuejiao Gu, Huajie Li, Zhiming Ge, Xiaojia Cai, Bing Jiang, Dan Wang, Mingyue Zheng, Tianfeng Xu, Sulin Zhang
Discovery of a Potent, Cooperative, and Selective SOS1 PROTAC ZZ151 with In Vivo Antitumor Efficacy in KRAS-Mutant Cancers. Journal of medicinal chemistry 66 (6) (2023)
Weilian Bao, Yan You, Jiahui Ni, Hui Hou, Jiaren Lyu, Guize Feng, Yirui Wang, Keyuan You, Sulin Zhang, Lijie Zhang, Xinyue Cao, Xu Wang, Haidong Li, Hong Li, Jiake Xu, Chen-Ying Liu, Xiaomin Luo, Peng Du, Dao-Feng Chen, Xiaoyan Shen
Inhibiting sorting nexin 10 promotes mucosal healing through SREBP2-mediated stemness restoration of intestinal stem cells. Science advances 9 (35) (2023)
Zehui Zhou, Guizhen Zhou, Chuan Zhou, Zisheng Fan, Rongrong Cui, Yupeng Li, Rui Li, Yuejiao Gu, Huajie Li, Zhiming Ge, Xiaojia Cai, Bing Jiang, Dan Wang, Mingyue Zheng, Tianfeng Xu, Sulin Zhang
Discovery of a Potent, Cooperative, and Selective SOS1 PROTAC ZZ151 with In Vivo Antitumor Efficacy in KRAS-Mutant Cancers. Journal of medicinal chemistry 66 (6) (2023)
Feisheng Zhong, Xiaolong Wu, Ruirui Yang, Xutong Li, Dingyan Wang, Zunyun Fu, Xiaohong Liu, XiaoZhe Wan, Tianbiao Yang, Zisheng Fan, Yinghui Zhang, Xiaomin Luo, Kaixian Chen, Sulin Zhang, Hualiang Jiang, Mingyue Zheng
Drug target inference by mining transcriptional data using a novel graph convolutional network framework. Protein & cell (2021)

Sulin Zhang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sulin Zhang